Global Preterm Birth Prevention & Management Market Overview:
Global Preterm Birth Prevention & Management Market Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2025-2032, Considering the Base Year As 2024.
Global Preterm Birth Prevention & Management Market Report 2025 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2025-2032.This research study of Preterm Birth Prevention & Management involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Preterm Birth Prevention & Management Market:
The Preterm Birth Prevention & Management Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Preterm Birth Prevention & Management Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Preterm Birth Prevention & Management Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Preterm Birth Prevention & Management market has been segmented into:
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antibiotics Therapy
Heparin Profylaxis Therapy
and Others
By Application, Preterm Birth Prevention & Management market has been segmented into:
Oral
Parenteral
and Vaginal
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Preterm Birth Prevention & Management market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Preterm Birth Prevention & Management market.
Top Key Players Covered in Preterm Birth Prevention & Management market are:
Covis Pharma GmbH. (AMAG Pharmaceuticals
Inc.)
Ferring B.V.
Pfizer Inc.
Takeda Pharmaceutical Company Limited.
ObsEva
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Industry Dynamics and Opportunity Analysis
3.1.1 Growth Drivers
3.1.2 Limiting Factors
3.1.3 Growth Opportunities
3.1.4 Challenges and Risks
3.2 Market Trend Analysis
3.3 Strategic Pestle Overview
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Mapping
3.6 Regulatory Framework
3.7 Princing Trend Analysis
3.8 Patent Analysis
3.9 Technology Evolution
3.10 Investment Pockets
3.11 Import-Export Analysis
Chapter 4: Preterm Birth Prevention & Management Market Type
4.1 Preterm Birth Prevention & Management Market Snapshot and Growth Engine
4.2 Preterm Birth Prevention & Management Market Overview
4.3 Progesterone Therapy
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Progesterone Therapy: Geographic Segmentation Analysis
4.4 Corticosteroid Therapy
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Corticosteroid Therapy: Geographic Segmentation Analysis
4.5 Tocolytics Therapy
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Tocolytics Therapy: Geographic Segmentation Analysis
4.6 Antibiotics Therapy
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Antibiotics Therapy: Geographic Segmentation Analysis
4.7 Heparin Profylaxis Therapy
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Heparin Profylaxis Therapy: Geographic Segmentation Analysis
4.8 and Others
4.8.1 Introduction and Market Overview
4.8.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.8.3 and Others: Geographic Segmentation Analysis
Chapter 5: Preterm Birth Prevention & Management Market Application
5.1 Preterm Birth Prevention & Management Market Snapshot and Growth Engine
5.2 Preterm Birth Prevention & Management Market Overview
5.3 Oral
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Oral: Geographic Segmentation Analysis
5.4 Parenteral
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Parenteral: Geographic Segmentation Analysis
5.5 and Vaginal
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 and Vaginal: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Preterm Birth Prevention & Management Market Share by Manufacturer (2023)
6.1.3 Concentration Ratio(CR5)
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 COVIS PHARMA GMBH. (AMAG PHARMACEUTICALS
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Operating Business Segments
6.2.5 Product Portfolio
6.2.6 Business Performance
6.2.7 Key Strategic Moves and Recent Developments
6.3 INC.)
6.4 FERRING B.V.
6.5 PFIZER INC.
6.6 TAKEDA PHARMACEUTICAL COMPANY LIMITED.
6.7 OBSEVA
Chapter 7: Global Preterm Birth Prevention & Management Market By Region
7.1 Overview
7.2. North America Preterm Birth Prevention & Management Market
7.2.1 Historic and Forecasted Market Size by Segments
7.2.2 Historic and Forecasted Market Size By Type
7.2.2.1 Progesterone Therapy
7.2.2.2 Corticosteroid Therapy
7.2.2.3 Tocolytics Therapy
7.2.2.4 Antibiotics Therapy
7.2.2.5 Heparin Profylaxis Therapy
7.2.2.6 and Others
7.2.3 Historic and Forecasted Market Size By Application
7.2.3.1 Oral
7.2.3.2 Parenteral
7.2.3.3 and Vaginal
7.2.4 Historic and Forecast Market Size by Country
7.2.4.1 US
7.2.4.2 Canada
7.2.4.3 Mexico
7.3. Eastern Europe Preterm Birth Prevention & Management Market
7.3.1 Historic and Forecasted Market Size by Segments
7.3.2 Historic and Forecasted Market Size By Type
7.3.2.1 Progesterone Therapy
7.3.2.2 Corticosteroid Therapy
7.3.2.3 Tocolytics Therapy
7.3.2.4 Antibiotics Therapy
7.3.2.5 Heparin Profylaxis Therapy
7.3.2.6 and Others
7.3.3 Historic and Forecasted Market Size By Application
7.3.3.1 Oral
7.3.3.2 Parenteral
7.3.3.3 and Vaginal
7.3.4 Historic and Forecast Market Size by Country
7.3.4.1 Russia
7.3.4.2 Bulgaria
7.3.4.3 The Czech Republic
7.3.4.4 Hungary
7.3.4.5 Poland
7.3.4.6 Romania
7.3.4.7 Rest of Eastern Europe
7.4. Western Europe Preterm Birth Prevention & Management Market
7.4.1 Historic and Forecasted Market Size by Segments
7.4.2 Historic and Forecasted Market Size By Type
7.4.2.1 Progesterone Therapy
7.4.2.2 Corticosteroid Therapy
7.4.2.3 Tocolytics Therapy
7.4.2.4 Antibiotics Therapy
7.4.2.5 Heparin Profylaxis Therapy
7.4.2.6 and Others
7.4.3 Historic and Forecasted Market Size By Application
7.4.3.1 Oral
7.4.3.2 Parenteral
7.4.3.3 and Vaginal
7.4.4 Historic and Forecast Market Size by Country
7.4.4.1 Germany
7.4.4.2 UK
7.4.4.3 France
7.4.4.4 The Netherlands
7.4.4.5 Italy
7.4.4.6 Spain
7.4.4.7 Rest of Western Europe
7.5. Asia Pacific Preterm Birth Prevention & Management Market
7.5.1 Historic and Forecasted Market Size by Segments
7.5.2 Historic and Forecasted Market Size By Type
7.5.2.1 Progesterone Therapy
7.5.2.2 Corticosteroid Therapy
7.5.2.3 Tocolytics Therapy
7.5.2.4 Antibiotics Therapy
7.5.2.5 Heparin Profylaxis Therapy
7.5.2.6 and Others
7.5.3 Historic and Forecasted Market Size By Application
7.5.3.1 Oral
7.5.3.2 Parenteral
7.5.3.3 and Vaginal
7.5.4 Historic and Forecast Market Size by Country
7.5.4.1 China
7.5.4.2 India
7.5.4.3 Japan
7.5.4.4 South Korea
7.5.4.5 Malaysia
7.5.4.6 Thailand
7.5.4.7 Vietnam
7.5.4.8 The Philippines
7.5.4.9 Australia
7.5.4.10 New Zealand
7.5.4.11 Rest of APAC
7.6. Middle East & Africa Preterm Birth Prevention & Management Market
7.6.1 Historic and Forecasted Market Size by Segments
7.6.2 Historic and Forecasted Market Size By Type
7.6.2.1 Progesterone Therapy
7.6.2.2 Corticosteroid Therapy
7.6.2.3 Tocolytics Therapy
7.6.2.4 Antibiotics Therapy
7.6.2.5 Heparin Profylaxis Therapy
7.6.2.6 and Others
7.6.3 Historic and Forecasted Market Size By Application
7.6.3.1 Oral
7.6.3.2 Parenteral
7.6.3.3 and Vaginal
7.6.4 Historic and Forecast Market Size by Country
7.6.4.1 Turkiye
7.6.4.2 Bahrain
7.6.4.3 Kuwait
7.6.4.4 Saudi Arabia
7.6.4.5 Qatar
7.6.4.6 UAE
7.6.4.7 Israel
7.6.4.8 South Africa
7.7. South America Preterm Birth Prevention & Management Market
7.7.1 Historic and Forecasted Market Size by Segments
7.7.2 Historic and Forecasted Market Size By Type
7.7.2.1 Progesterone Therapy
7.7.2.2 Corticosteroid Therapy
7.7.2.3 Tocolytics Therapy
7.7.2.4 Antibiotics Therapy
7.7.2.5 Heparin Profylaxis Therapy
7.7.2.6 and Others
7.7.3 Historic and Forecasted Market Size By Application
7.7.3.1 Oral
7.7.3.2 Parenteral
7.7.3.3 and Vaginal
7.7.4 Historic and Forecast Market Size by Country
7.7.4.1 Brazil
7.7.4.2 Argentina
7.7.4.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Preterm Birth Prevention & Management Scope:
|
Report Data
|
Preterm Birth Prevention & Management Market
|
|
Preterm Birth Prevention & Management Market Size in 2025
|
USD XX million
|
|
Preterm Birth Prevention & Management CAGR 2025 - 2032
|
XX%
|
|
Preterm Birth Prevention & Management Base Year
|
2024
|
|
Preterm Birth Prevention & Management Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Covis Pharma GmbH. (AMAG Pharmaceuticals, Inc.), Ferring B.V., Pfizer Inc., Takeda Pharmaceutical Company Limited., ObsEva.
|
|
Key Segments
|
By Type
Progesterone Therapy
Corticosteroid Therapy
Tocolytics Therapy
Antibiotics Therapy
Heparin Profylaxis Therapy
and Others
By Applications
Oral
Parenteral
and Vaginal
|
